Since previous studies showed that loss of CYLD function leads to the suppression of apoptosis by NF-κB hyperactivation in malignant tumors [7,8,9,10,11], we next sought to determine whether the suppression of apoptosis was involved in cisplatin resistance caused by CYLD down-regulation in SAS cells. Here, NFKB1 is linked to cancer.